PUBLISHED 2003
This fact sheet focuses on the most common side effects of efavirenz, and includes people’s personal stories explaining how they dealt with them. This information is intended to prepare and inform you, so that you don’t feel scared if something comes up. The fact sheet does not aim to provide all the available information about efavirenz. It does not endorse efavirenz or warn against it and is not a substitute for your doctor’s advice.
It’s easier to deal with the side effects of HIV drugs if you are informed about them before they happen. When you start any HIV treatment, temporary side effects such as headaches, nausea and diarrhoea are common. This fact sheet focuses on the most common side effects of efavirenz, and includes people’s personal stories explaining how they dealt with them. This information is intended to prepare and inform you, so that you don’t feel scared if something comes up. The fact sheet does not aim to provide all the available information about efavirenz. It does not endorse efavirenz or warn against it and is not a substitute for your doctor’s advice.
Efavirenz belongs to a group of medicines called non-nucleoside reverse transcriptase inhibitors (NNRTIs). Efavirenz works by interrupting the formation of new HIV particles in already infected cells. This helps reduce the amount of virus in the blood.
Efavirenz is always taken with two or more other HIV drugs. For adults and children weighing more than 40kg, the normal dose is 600mg once a day, preferably on an empty stomach. Efavirenz is available as one 600mg tablet, and smaller doses in different formulations are also available.
Efavirenz interacts with a number of drugs, including some HIV drugs. If you are taking other drugs that interact with efavirenz, your doctor will compensate for this by altering the dosing. Efavirenz should not be taken with St John’s Wort (Hypericum perforatum), a herbal product sold as a dietary supplement.
Efavirenz helps most people with HIV infection, but it may have unwanted side effects. Not everyone who takes efavirenz gets side effects. However for those that do, the most common appear to be
Trials have shown that these side effects can occur in more than 50% of people and may last an average of two to four weeks.
Try taking efavirenz at bedtime if dizziness is a problem. Remember that dizziness is a side effect that is usually temporary and goes away by itself after a few weeks. If you have sick leave or holiday leave, consider taking some time off when starting efavirenz.
Theresa: My husband has been positive for three years. He started on efavirenz, 3TC and d4T. He was really dizzy and shaky at first. It took him about a month and a half to feel better. He is doing great with the trio now.
Robert: The most serious side effect was dizziness, which my doctor didn’t warn me about. I took efavirenz at night. The dizziness was so severe that I would be stumbling into walls when I got up at night to go to the toilet. Moving to a bedroom nearer the toilet helped. The dizziness went away after a few weeks.
Susan: The dizziness was so bad that I was falling over at times. I was taking the drug at about 5pm each day. After discussing it with my specialist he suggested that I take it when I went to bed. Taking it at bedtime stopped me experiencing the dizziness. I found the drug is working very well for me in combination with 3TC and tenofovir. My viral load is undetectable and my T Cells are 1120.
It is important to remember that mood swings can be related to efavirenz. Any sudden onset of crankiness and irritability will almost certainly be due to the temporary side effects of efavirenz. Dosing at bedtime can be helpful.
Michael: I’ve been been on efavirenz for five years. I take it just before I go to sleep. If I take it earlier, two hours afterwards I get an uncomfortable feeling of edginess.
Tony: My doctor told me to take efavirenz in the morning. I started taking it at 7.30am with a cup of coffee – I don’t eat breakfast. The first noticeable side effect was that a couple of hours after the morning dose I’d feel anxious, jittery and nervous. This went on for three months till I brought it up with my doctor, who suggested taking it at night. When I changed to night-time dosing the side effects went away.
Consider these strategies for managing insomnia:
Michael: When I started efavirenz, my doctor warned me to expect some insomnia and offered me sleeping medication. I don’t like taking sleeping pills and I’ve found alternative sleeping medication at bedtime that provides a good nights sleep. The vivid dreams haven’t gone away but they are not nightmares.
Patrick: I still get insomnia occasionally.I am not sure if this is due to the efavirenz or that I am experiencing the same amount of insomnia as many other people. Perhaps it is a consequence of living in a busy part of the city.
Rebecca: The sleeplessness has never gone away. My doctor prescribed some sleeping medication but that gave me a hangover. Now I take another sleeping medication which works very well and doesn’t cause a hangover.
Susan: I still had the vivid dreams for a while but that soon stopped. Taking it at bedtime stopped me experiencing the dizziness and sleep disturbance.
Mild to moderate rash (pinkish, itchy swellings on the skin) during the first few weeks of therapy has been reported in clinical trials with efavirenz. Fortunately the rash usually goes away without any need to discontinue efavirenz. Always report a rash to your doctor. Avoid things that can aggravate a rash such as:
Avoid scratching or rubbing the rash as this may cause it to bleed or become infected. A rash and its surrounding area should be cleaned using a gentle soap and patted dry. Non-allergic moisturizers and creams can help keep the skin moist and control itching (check with your doctor or dermatologist). If itching and scratching are severe, ask your doctor about medications to reduce itchiness.
There can be a wide variety in the way people process efavirenz in the body. This means some people may have blood levels of efavirenz that are below or above the recommended level. In a small number of cases, abnormally high blood levels of efavirenz have been identified as the causefor depression and abnormal thinking. Therapeutic drug monitoring – measuring blood levels of efavirenz – enables doctors to fine tune the dose so that effective drug levels are maintained and side effects are minimised. Never change your dose of efavirenz without consulting your doctor.
Patrick: I began treatment including efavirenz in the first week of March 2000.
I started experiencing suicidal thoughts in July 2001 which was 16 months after commencing efavirenz. Around that time I had problems at work which were causing me discomfort and they became the trigger for suicidal thoughts. I made preparations for suicide but thankfully I hesitated. I just could not take that next step. I rang a friend, explained everything and she was with me within minutes. The next morning I rang the clinic to ask for help. The medical and psychological staff were amazing. They were able to bring sense to a senseless situation. I felt I was going crazy but it was suggested and later proven to be a result of high levels of efavirenz. When my levels of efavirenz were measured they were six times the level they needed to be to contain the HIV. Four times the level is where they would normally expect the development of neurological side effects. My dose was lowered to 400mg daily of efavirenz. Within several weeks my mental state improved. The new dose appears to be working. My viral load remains undetectable and my CD4 count is still increasing.
Glucose is a simple sugar found in the blood, and is the body’s main source of energy. A class of HIV medication called protease inhibitors can interfere with the way the body uses glucose. In some cases this can increase a person’s risk of developing diabetes.
Some protease inhibitors can also interfere with blood fats and cholesterol levels, potentially increasing the risk of heart disease. Switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor (NNRTI) may improve bloodfat and cholesterol levels. However efavirenz, which is a NNRTI, has been shown to raise cholesterol levels in some people. Medication is available which can lower cholesterol levels.
Robert: I had to stop taking my previous drug combination after two years of successful suppression of the virus, because of lipodystrophy, raised cholesterol, lipid imbalances and insulin intolerance. I switched my protease inhibitor for efavirenz eighteen months ago (but kept two other drugs from my previous combination) because I was worried about a history of heart problems on both sides of my family. The switch has been very successful for me, though some of the brain chemistry changes have been challenging to deal with – sleep disturbance, mood swings and lethargy. I’m getting used to these now with the help of antidepressants and a very understanding and long-suffering partner.
Rebecca: The protease inhibitors were causing lipid/blood sugar problems which would only become worse as time went on. Efavirenz, therefore, is a credible alternative to the protease inhibitors for me personally. The need for effective viral suppression outweighs the side effects.
Not everyone experiences some or all of the side effects. Starting or changing HIV medication can be stressful itself. Keep in mind that some symptoms could be caused by stress rather than efavirenz. Although the personal stories in this fact sheet describe some difficult experiences, they demonstrate that side effects are either short-lived or, together with their doctors’ assistance, manageable. Remember that help is available and don’t hesitate to ask for it.
Services provided by ACON:
Services from other organisations:
AIDSMEDS.COM Tips and Tricks on Taking Sustiva http://www.aidsmeds.com/drugs/SustivaTips/SustivaTips14.htm [2]
Becker S et al. Successful substitution of protease inhibitors with efavirenz in patients with undetectable viral loads – a prospective, randomized, multicenter, open-label study (DMP-049). Eighth Conference on Retroviruses and Opportunistic Infections, Chicago, Abstract 20, 2001.
Boyle, B. Managing Sustiva (efavirenz) Side Effects. www.hivandhepatitis.com [3]
Fisac C et al. A randomized trial of metabolic and body composition changes in patients switching from PI-containing regimens to abacavir (ABC), efavirenz (EFV) or nevirapine (NVP). Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, Abstract P92, 2002.
HIV i-Base Guide to avoiding & managing side effects, August 2002 (http://www.i-base.org.uk/ [4])
Kelly M et al. Long-term follow-up of efavirenz usage in patients with HIV disease. 12th Annual Conference of the Australasian Society for HIV Medicine, Melbourne, abstract 88, 2000.
Machon, K. Report on 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. October 23–26, Athens, Greece. www.napwa.org.au [5]
Marzolini, C., et al. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1 infected patients. AIDS 15:71–75, 2001.
Moyle,G. Associate Director of HIV Research and Associate Specialist in HIV/GU Medicine at Chelsea and Westminster Hospital, London, England. Managing CNS Effects of Efavirenz. www.medscape.com [6] July 1, 1999
National Heart Foundation, Risk Factors for Heart Disease. http://www.heartfoundation.com.au [7]
Ruiz NM, Bessen LJ, Manion DJ, et al. Potential adverse experiences associated with efavirenz in adults. [Abstract 655] 6th Conference on Retroviruses and Opportunistic Infections Chicago, February 1999.
Produced by the Health Promotion Unit of Positive Life NSW.
Copyright © February 2003 Positive Life NSW. This fact sheet may be copied for personal or organisational use provided you acknowledge Positive Life NSW.
This fact sheet was produced with the assistance of unconditional educational grants from Merck Sharpe & Dohme Australia and Gilead Sciences Pty Ltd.
| Attachment | Size | Type |
|---|---|---|
| PDF version [8] | 582.65 KB |
Links:
[1] http://positivelife.org.au/files/1.Efavirenz.jpg
[2] http://www.aidsmeds.com/drugs/SustivaTips/SustivaTips14.htm
[3] http://www.hivandhepatitis.com
[4] http://www.i-base.org.uk/
[5] http://www.napwa.org.au
[6] http://www.medscape.com
[7] http://www.heartfoundation.com.au
[8] http://positivelife.org.au/files/1_Efavirenz.pdf